Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Lancet industry 3600 synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends (USD Million & Units)
2.4 Type trends (USD Million & Units)
2.5 Size trends
2.6 End-use trends
Chapter 3 Lancet Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of diabetes across the world
3.2.1.2 Rising technological advancements
3.2.1.3 Increasing investments by public and private organizations for diabetes care
3.2.1.4 Upsurge in geriatric population base
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing number of infections and injuries from lancets
3.2.2.2 Rigorous regulatory framework regarding diabetes care
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By size
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Lancet Market Size and Forecast, By Type (USD Million & Units)
5.1 Key trends, by type
5.2 Safety lancets
5.3 Standard lancets
5.4 Manually activated lancets
5.4.1 Push button lancets
5.4.2 Side button lancets
5.5 Automatically activated lancets
Chapter 6 Lancet Market Size and Forecast, By Size (USD Million)
6.1 Key trends, by size
6.2 22G and below
6.3 23G-33G
6.4 Above 33G
Chapter 7 Lancet Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Clinics
7.4 Homecare settings
7.5 Ambulatory surgical centers
7.6 Others
Chapter 8 Lancet Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Vietnam
8.4.8 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 AgaMatrix
9.2 Abbott Laboratories
9.3 All Medicus Co., Ltd.
9.4 Ascensia Diabetes Care Holdings AG
9.5 Arkray, Inc
9.6 B. Braun Melsungen AG
9.7 Bionime Corporation
9.8 DarioHealth Corp.
9.9 Dexcom, Inc.
9.10 Essenlife Bioscience, Inc.
9.11 F. Hoffmann-La Roche Ltd.
9.12 LifeScan Inc.
9.13 Medtronic
9.14 Nova Biomedical, Inc.
9.15 Sinocare Inc.
